Literature DB >> 11161400

Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas.

J M Arnold1, S C Mok, D Purdie, G Chenevix-Trench.   

Abstract

The molecular events that drive the initiation and progression of ovarian adenocarcinoma are not well defined. We have investigated changes in gene expression in ovarian cancer cell lines compared to an immortalized human ovarian surface epithelial cell line (HOSE) using a cDNA array. We identified 17 genes that were under-expressed and 10 genes that were over-expressed in the cell lines compared to the HOSE cells. One of the genes under-expressed in the ovarian cancer cell lines, Id3, a transcriptional inactivator, was selected for further investigation. Id3 mRNA was expressed at reduced levels in 6 out of 9 ovarian cancer cell lines compared to the HOSE cells while at the protein level, all 7 ovarian cancer cell lines examined expressed the Id3 protein at greatly reduced levels. Expression of Id3 mRNA was also examined in primary ovarian tumours and was found in only 12/38 (32%) cases. A search was conducted for mutations of Id3 in primary ovarian cancers using single stranded conformation polymorphism (SSCP) analysis. Only one nucleotide substitution, present also in the corresponding constitutional DNA, was found in 94 ovarian tumours. Furthermore no association was found between LOH at 1p36 and lack of expression of Id3. These data suggest that Id3 is not the target of LOH at 1p36.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161400      PMCID: PMC2363740          DOI: 10.1054/bjoc.2000.1620

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  52 in total

1.  Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction.

Authors:  P Liang; A B Pardee
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

2.  Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus.

Authors:  G Chenevix-Trench; J Leary; J Kerr; J Michel; R Kefford; T Hurst; P G Parsons; M Friedlander; S K Khoo
Journal:  Oncogene       Date:  1992-06       Impact factor: 9.867

3.  Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection.

Authors:  T K Blackwell; H Weintraub
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

4.  Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs).

Authors:  S W Tsao; S C Mok; E G Fey; J A Fletcher; T S Wan; E C Chew; M G Muto; R C Knapp; R S Berkowitz
Journal:  Exp Cell Res       Date:  1995-06       Impact factor: 3.905

5.  Positive selection of candidate tumor-suppressor genes by subtractive hybridization.

Authors:  S W Lee; C Tomasetto; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

6.  Structural organisation and chromosomal mapping of the human Id-3 gene.

Authors:  R W Deed; T Hirose; E L Mitchell; M F Santibanez-Koref; J D Norton
Journal:  Gene       Date:  1994-12-30       Impact factor: 3.688

7.  The cdc-2-related kinase, PISSLRE, is essential for cell growth and acts in G2 phase of the cell cycle.

Authors:  S Li; T K MacLachlan; A De Luca; P P Claudio; G Condorelli; A Giordano
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

8.  Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

Authors:  S D Merajver; T M Pham; R F Caduff; M Chen; E L Poy; K A Cooney; B L Weber; F S Collins; C Johnston; T S Frank
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

9.  Increased expression of the NME1 gene is associated with metastasis in epithelial ovarian cancer.

Authors:  J A Leary; J Kerr; G Chenevix-Trench; C P Doris; T Hurst; C R Houghton; M L Friedlander
Journal:  Int J Cancer       Date:  1995-06-22       Impact factor: 7.396

10.  A novel putative tyrosine kinase receptor with oncogenic potential.

Authors:  J W Janssen; A S Schulz; A C Steenvoorden; M Schmidberger; S Strehl; P F Ambros; C R Bartram
Journal:  Oncogene       Date:  1991-11       Impact factor: 9.867

View more
  7 in total

1.  The impact of genomic alterations on the transcriptome: a prostate cancer cell line case study.

Authors:  J Chaudhary; M Schmidt
Journal:  Chromosome Res       Date:  2006-07-12       Impact factor: 5.239

2.  The Id3/E47 axis mediates cell-cycle control in human pancreatic ducts and adenocarcinoma.

Authors:  Seung-Hee Lee; Ergeng Hao; Alice Kiselyuk; James Shapiro; David J Shields; Andrew Lowy; Fred Levine; Pamela Itkin-Ansari
Journal:  Mol Cancer Res       Date:  2011-04-15       Impact factor: 5.852

3.  Overexpression of Id3 induces apoptosis of A549 human lung adenocarcinoma cells.

Authors:  X-J Li; C-D Zhu; W Yu; P Wang; F-F Chen; X-Y Xia; B Luo
Journal:  Cell Prolif       Date:  2011-12-07       Impact factor: 6.831

4.  Expression Profiles of ID and E2A in Ovarian Cancer and Suppression of Ovarian Cancer by the E2A Isoform E47.

Authors:  Yong-Jae Lee; Eun-Ji Nam; Sunghoon Kim; Young-Tae Kim; Pamela Itkin-Ansari; Sang-Wun Kim
Journal:  Cancers (Basel)       Date:  2022-06-12       Impact factor: 6.575

5.  Effects of upregulation of Id3 in human lung adenocarcinoma cells on proliferation, apoptosis, mobility and tumorigenicity.

Authors:  F-F Chen; Y Liu; F Wang; X-J Pang; C-D Zhu; M Xu; W Yu; X-J Li
Journal:  Cancer Gene Ther       Date:  2015-09-18       Impact factor: 5.987

6.  Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma.

Authors:  J M Arnold; P R Huggard; M Cummings; G A Ramm; G Chenevix-Trench
Journal:  Br J Cancer       Date:  2005-06-06       Impact factor: 7.640

7.  Increased expression of ID2, PRELP and SMOC2 genes in patients with endometriosis.

Authors:  F M Araujo; J Meola; J C Rosa-E-Silva; C C P Paz; R A Ferriani; A A Nogueira
Journal:  Braz J Med Biol Res       Date:  2017-07-03       Impact factor: 2.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.